Prognosis of prostate cancer by artificial neural networks

Expert Systems with Applications

Volumn 37, Issue 9, 2010, Pages 6646-6650

  Saritas, Ismail ^a   Ali Ozkan, Ilker ^a   Sert, Ibrahim Unal ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Artificial neural network; Prognosis of prostate cancer; Prostate cancer; Prostate specific antigen

Indexed keywords

ANTIGENS; BIOPSY; DEEP NEURAL NETWORKS; DIAGNOSIS; NEURAL NETWORKS; PATIENT MONITORING; UROLOGY;

AGE DATA; CONFUSION MATRICES; HIGH RATE; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; ROC ANALYSIS;

DISEASES;

EID: 80053578933     PISSN: 09574174     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eswa.2010.03.056     Document Type: Article

References (23)

1. Abbod, M. F., Keyserlingk, D. G., Linkens, D. A., & Mahfouf, M. (2001). Survey of utilization of fuzzy technology in medicine and healthcare. Fuzzy Sets and Systems, 120, 331-349. (Pubitemid 32407907)
2. Allahverdi, N. (2002). Expert systems. An artificial intelligence application. Istanbul: Atlas Press. 248p.
3. Allahverdi, N., & Yaldiz, S. (1998). Expert system applications in medicine and example of design of a pre-diagnosis expert system. In Proceedings of the second Turkish-German joint computer application days, 15-16 October 1998, Konya (pp. 175-192).
4. Boegla, K., Adlassniga, K. P., Hayashic, Y., Rothenfluhd, T. E., & Leiticha, H. (2002). Knowledge acquisition in the fuzzy knowledge representation framework of a medical consultation system. Artificial Intelligence in Medicine, 676, 1-26.
5. Brawer, M. K., & Kirby, R. (1999). Prostate specific antigen (2nd ed.). Health Press. 92p.
6. Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Flanigan, R. C., Patel, A., et al. (1998). Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial. Journal of American Medical Association (JAMA), 279, 1542-1547. (Pubitemid 28233009)
7. Cinar, M., Engin, M., Engin, E. Z., & Ates, Y. Z. (2009). Early prostate cancer diagnosis by using artificial neural networks. Expert Systems with Applications, 6357-6361.
8. Lorenz, A., Blum, M., Ermert, H., & Senge, Th. (1997). Comparison of different neurofuzzy classification systems for the detection of prostate cancer in ultrasonic images. Ultrasonics Symposium, 2, 1201-1204.
9. Metlin, C., Lee, F., & Drago, J. (1991). The American Cancer Society National prostate cancer detection, project: Findings on the detection of early prostate cancer in 2425 men. Cancer, 67, 2949-2958.
10. Metz, C. E. (1978). Basic principles of ROC analysis. Seminars in Nuclear Medicine, 283-298. (Pubitemid 9075026)
11. Nguyen, H. P., & Kreinovich, V. (2001). Fuzzy logic and its applications in medicine. International Journal of Medical Informatics, 62, 165-173. (Pubitemid 32722237)
12. Prostate Cancer Symptoms. http://www.medicinenet.com/Prostate-Cancer/ page3.htm. Arrived March 2009.
13. Prostate Online Calculator. http://www.compass.fhcrc.org/edrnnci/bin/ calculator/main.asp?t=prostate&sub=s1&m=&v=prostate&x= Prostate%20Cancer. Arrived February 2009.
14. Ronco, A. L., & Fernandez, R. (1999). Improving ultrasonographic diagnosis of prostate cancer with neural networks. Ultrasound in Medicine and Biology, 25(5), 729-733. (Pubitemid 29270387)
15. Saritas, I. (2003). Fuzzy control in medicine. Master thesis. Selcuk University.
16. Saritas, I., Allahverdi, N., & Sert, I. U. (2003). A fuzzy expert system design for diagnosis of prostate cancer. In: Proceedings of the international conference on computer systems and technologies - CompSysTech'2003, Sofia, Bulgaria (pp. 345-351).
17. Seker, H., Odetayo, M., Petrovic, D., & Naguib, R. N. G. (2003). A fuzzy logic based method for prognostic decision making in breast and prostate cancers. IEEE
18. Transactions on Information Technology in Biomedicine, 7, 114-122.
19. Shin Egawa, M. D., Shigehiro Soh, M. D., Makoto Ohori, M. D., Toyoaki Uchida, M. D., Kazuo Gohji, M. D., Akio Fujii, M. D., et al. (1997). The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in Japan. Cancer, 79, 90-98.
20. Turker, N., Tokan, F., & Yildirim, T. (2005). Determination of artificial neural networks performances by ROC analysis on the diagnosis of heart disease. Biomedical Engineering National Congress, 206-208.
21. Van Cangh, P. J., De Nayer, P., De Vischer, L., Sauvage, P., Tombal, B., Lorge, F., et al. (1996a). Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer. The Prostate, 29, 30-34. (Pubitemid 26412174)
22. Van Cangh, P. J., De Nayer, P., De Vischer, L., Sauvage, P., Tombal, B., Lorge, F., et al. (1996b). Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8-10 ng/ml total PSA. Urology, 48, 67-70. (Pubitemid 26425539)
23. Wichard, J. D., Cammann, H., Stephan, C., & Tolxdorff, T. (2008). Classification models for early detection of prostate cancer. Hindawi Publishing Corporation Journal of Biomedicine and Biotechnology.